| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/17/2010 | WO2010067076A2 Pulse sequencing with hyperpolarisable nuclei |
| 06/17/2010 | WO2010066815A2 Encapsulating system for cest imaging with chelate q greater than or equal to 2 |
| 06/17/2010 | WO2010020673A3 Transcutaneous organ function measurement |
| 06/17/2010 | WO2009158698A9 Targeted delivery of imaging probes for in vivo cellular imaging |
| 06/17/2010 | US20100154071 Fxdy5 modulators for treating, diagnosing, and detecting cancer |
| 06/17/2010 | US20100150944 Methods and compositions for diagnosis and treatment of depression and anxiety |
| 06/17/2010 | US20100150928 Methods and compositions relating to zpa polypeptides |
| 06/17/2010 | US20100150925 Treatment of b-cell cancers with anti-cd70 antibody-drug conjugates |
| 06/17/2010 | US20100150843 Peptide imaging agents |
| 06/17/2010 | US20100150842 Method and Kit for Detecting Resistance in Living Organisms |
| 06/17/2010 | US20100150841 Use of Tumor Necrosis Factor-Alpha P75 Receptor for the Reduction of Inflammation |
| 06/17/2010 | US20100150840 Small-molecule agonists for type-2 orexin receptor |
| 06/17/2010 | US20100150839 Compositions and Methods for Modulating Cognitive Function |
| 06/17/2010 | US20100150838 Methods for evaluating osteoarthritis risk |
| 06/17/2010 | US20100150837 ANTIBODIES AGAINST GPIb alpha |
| 06/17/2010 | US20100150833 Compounds and amyloid probes thereof for therapeutic and imaging uses |
| 06/17/2010 | US20100150832 Biodegradable polyketal polymers and methods for their formation and use |
| 06/17/2010 | US20100150829 Antibodies to IL-6 and use thereof |
| 06/16/2010 | EP2195335A1 Diagnostic agent |
| 06/16/2010 | EP2194866A1 Device, gas mixture and method for lung diagnosis |
| 06/16/2010 | EP1651958B1 Novel chemiluminescent compounds and their use |
| 06/16/2010 | EP1370291B1 Device and method for the photodynamic diagnosis of tumor tissue |
| 06/16/2010 | CN101743022A Optical imaging agents |
| 06/16/2010 | CN101735383A Zinc oxide quantum dot wrapped by poly(N, N-dimethyamino ethyl methacrylate)-polymethacrylate, preparation and application thereof |
| 06/16/2010 | CN101732735A Gas emulsion type ultrasound contrast agent microspheres using carbohydrate as main material and preparation method thereof |
| 06/16/2010 | CN101732734A Use of ivabradine as a diagnostic agent in the coronary angiography method using multi-cut computed tomography |
| 06/16/2010 | CN101732733A CT imaging contrast agent and preparation method thereof |
| 06/16/2010 | CN101732732A Bovine type tuberculin standard substance and preparation method thereof |
| 06/16/2010 | CN101732723A Polyethylene glycol-poly(lactic-co-glycolic acid)-polylysine nano-delivery system, preparation method and application thereof |
| 06/15/2010 | US7737258 Complementary determining regions capable binding to the same antigen as the monoclonal antibody 8H9; inhibit competitive binding; isolated scFv of monoclonal antibody 8H9, antigen, antitumor agents |
| 06/15/2010 | US7737255 monoclonal antibodies used for analyzing changes in the levels of cancer specific genes in cells, tissues or bodily fluids; medical prognosis |
| 06/15/2010 | US7737252 Peptide-based compounds |
| 06/15/2010 | US7737250 Peptides for treating axonal damage, inhibition of neurotransmitter release and pain transmission, and blocking calcium influx in neurons |
| 06/15/2010 | US7736646 Methods for modulating angiogenesis with apelin compositions |
| 06/15/2010 | US7736640 administering to mammal more than one dose of a composition comprising live Newcastle Disease Virus in an amount sufficient to cause tumor regression |
| 06/15/2010 | US7736625 Light stabilized in vivo stain composition and method of manufacture |
| 06/15/2010 | US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 06/15/2010 | US7736621 diagnosing the effect of a depression treatment upon a patient suffering from depression, by monitoring the level and function of a blood component selected from a beta-arrestin, a G-protein coupled receptor kinase; administration of a serotonin specific reuptake inhibitor |
| 06/15/2010 | US7736620 polyvinylpyridinium.tetrakis (aryltrifluoromethyl propanedionato) europate, which steadily emits red light by ultraviolet irradiation and has high dispersibility when applied to a glass substrate or mixed with plastics |
| 06/15/2010 | US7736619 Predetermined shape; hydrogen bonded polyvinyl alcohol; polyvinylpyrrolidone, and/or polyethylene glycol and water; exposing to freeze/thaw and/or dehydration/re-hydration cycles; heat treating until optically clear; high intensity focused ultrasound |
| 06/15/2010 | CA2250080C Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 06/10/2010 | WO2010065079A2 Antibodies to il-6 and use thereof |
| 06/10/2010 | WO2010065077A2 Antagonists of il-6 to prevent or treat thrombosis |
| 06/10/2010 | WO2010063714A1 Method for producing an inhalation atmosphere for provoking allergens |
| 06/10/2010 | WO2010063701A2 In vivo imaging method |
| 06/10/2010 | WO2010063491A2 Transport-mediating colloidal pharmaceutical compounds |
| 06/10/2010 | WO2010063483A2 Active ingredient-peptide construct for extracellular enrichment |
| 06/10/2010 | WO2010063403A2 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation |
| 06/10/2010 | WO2010012473A3 Hydrolase-specific nanosensors, methods for producing them and uses in molecular imaging |
| 06/10/2010 | US20100146662 Use of r-genes as a selection marker in plant transformation and use of cisgenes in plant transformation |
| 06/10/2010 | US20100146659 Plant Virus Designated Tomato Marchitez Virus |
| 06/10/2010 | US20100146642 Methods and compositions relating to PBK1 |
| 06/10/2010 | US20100145441 Therapeutic agents for angiogenesis-related diseases comprising chondromodulin-i as active ingredient |
| 06/10/2010 | US20100143360 Human vascular endothelial growth factor 2 |
| 06/10/2010 | US20100143263 Magnetic resonance imaging contrast agents comprising zinc-containing magnetic metal oxide nanoparticles |
| 06/10/2010 | US20100143262 Method for Identifying Allergenic Proteins And Peptides |
| 06/10/2010 | US20100143261 Composition for the diagnosis, prevention or treatment of diseases related to cells expressing il-8 or gro-alpha, comprising ucb-mscs |
| 06/10/2010 | US20100143259 Fluorescent microspheres, the preparation method and uses thereof |
| 06/10/2010 | US20100143258 Tumor margin imaging agents |
| 06/10/2010 | US20100143257 Prevention of Cancers by Immunization |
| 06/10/2010 | US20100143256 Electroencephalography based systems and methods for selecting therapies and predicting outcomes |
| 06/10/2010 | US20100143255 Fig4 gene mutations in neurodegeneration |
| 06/10/2010 | US20100143254 Molecules with reduced half-lives, compositions and uses thereof |
| 06/10/2010 | US20100143251 Compounds and amyloid probes thereof for therapeutic and imaging uses |
| 06/10/2010 | US20100143250 Compounds for the diagnosis of apoptosis |
| 06/10/2010 | US20100143244 Monoclonal antibodies to human thymidine kinase to treat cancer |
| 06/10/2010 | US20100143243 Frozen compositions and methods for piercing a substrate |
| 06/10/2010 | US20100143241 Method and apparatus for delivery of agents across the blood brain barrier |
| 06/10/2010 | CA2808320A1 Sparc binding peptides and uses thereof |
| 06/10/2010 | CA2745923A1 Sparc binding scfvs |
| 06/10/2010 | CA2745592A1 Transport-mediating colloid medicinal compounds |
| 06/10/2010 | CA2745364A1 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation |
| 06/09/2010 | EP2194067A2 Antibodies to insulin-like growth factor I receptor (IGF-IR) |
| 06/09/2010 | EP2193137A1 Organic/inorganic hybrid nanoparticulates made from iron carboxylates |
| 06/09/2010 | EP2193136A1 Solid inorganic/organic hybrid with modified surface |
| 06/09/2010 | EP2193115A1 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method |
| 06/09/2010 | EP2192927A1 Ed-b fibronectin as stratification marker for anti-tumor drugs |
| 06/09/2010 | EP1937315B1 Imaging agent comprising iron containing colloidal particle conjugated to oligosaccharides |
| 06/09/2010 | CN1868546B Model for screening human scavenger receptor CD36 antagonist and its application |
| 06/09/2010 | CN101730549A polymers conjugated with platinum drugs |
| 06/09/2010 | CN101721719A Ultrasound contrast agent and preparation method thereof |
| 06/09/2010 | CN101721718A Lipid microbubble and preparation method thereof |
| 06/09/2010 | CN101721717A Method for preparing Fe2O3 nano particle with core-shell structure |
| 06/09/2010 | CN101721716A Dendrimer CT targeted contrast agent of load nano-Au particles and preparation method thereof |
| 06/09/2010 | CN101721709A Calcium phosphate and amphiphilic polymer composite medicament-carrying nano-microsphere, preparation method and application |
| 06/09/2010 | CN101297975B Contrast agent for MR cholangiopancreatography |
| 06/09/2010 | CN101270124B Novel method for purifying and preparing high-purity fluorandiol and fluorandiol salt |
| 06/09/2010 | CN101249020B Method and device for monitoring recording products use information |
| 06/08/2010 | US7732587 for treatment of TNF-mediated diseases, particularly including chronic inflammatory diseases |
| 06/08/2010 | US7732439 Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 06/08/2010 | US7732159 Using plasminogin activator concentration as indicator of tumor progress and antitumor drug efficacy |
| 06/08/2010 | US7731941 Brilliant Blue G (BBG) derivatives; alternative dye as surgical adjuvant in ophthalmic surgeries for membrane removing; vitreo-retinal disease: epiretinal membrane, diabetic retinopathy and macular edema; hypermature and congenital cataract; corneal transplantation; nontoxic, better dye ability |
| 06/08/2010 | US7731940 N-(2-[4-(2-methoxyphenyl)piperazinyl]ethyl)-N-(2-pyridyl)-N-(4-18F-fluoro-methylcyclohexane)carboxamide, used for treating panic, bipolar or seizure disorders, and as a quantitative tool for measuring serotonin concentration in the brain |
| 06/08/2010 | US7731939 Killed cells of Mycobacterium avium as immunogens and mineral oil; immunocontraceptive vaccines such as gonadotropin releasing hormone (GnRH) |
| 06/08/2010 | US7731938 measuring the concentration of a fragment of cytokeratin 19 (CYFRA 21-1) and that of a low sensitivity marker such as neuron-specific enolase (NSE); early detection |
| 06/08/2010 | CA2602037C Indicator for orally administered compositions |
| 06/03/2010 | WO2010062854A2 Methods and compositions for using bleomycin-derivatized microbubbles |
| 06/03/2010 | WO2010062604A2 Models of thrombotic thrombocytopenic purpura and methods of use thereof |
| 06/03/2010 | WO2010062557A2 Multimodal imaging of atherosclerotic plaque targeted to lox-1 |
| 06/03/2010 | WO2010062536A2 Modified actinomycin-based nucleic acid stains and methods of their use |